A Study to Learn About the Study Medicine Called PF-08032562 in People with Advanced or Metastatic Solid Tumors

2025-524387-38-00 · tracked via the Priya Life Science EU tracker

Sponsor

Pfizer Inc

Sponsor type

Pharmaceutical company

Therapeutic area

Neoplasms

Decision date

25/09/2026

Enrollment target

Sites

France, Spain

Condition studied

metastatic/advanced breast cancer (BC) and colorectal cancer (CRC)

Eligibility

Age group

65+ years, 18-64 years

Sex

Female, Male

Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-524387-38-00 on CTIS ↗ ← All trials in the EU